Abstract
Imiquimod is a recently developed imidazoquinolin heterocyclic amine that is an immune response modifier. Treatment with topical 5% imiquimod cream has shown promising results in the treatment of genital warts in immunocompetent individuals. We report here the first case of successful treatment with topical 5% imiquimod cream of facial verrucae in an individual with human immunodeficiency virus.
MeSH terms
-
AIDS-Related Opportunistic Infections / diagnosis
-
AIDS-Related Opportunistic Infections / drug therapy*
-
Adjuvants, Immunologic / administration & dosage*
-
Administration, Topical
-
Adult
-
Aminoquinolines / administration & dosage*
-
Facial Dermatoses / diagnosis
-
Facial Dermatoses / drug therapy
-
Follow-Up Studies
-
Humans
-
Imiquimod
-
Male
-
Ointments
-
Treatment Outcome
-
Warts / diagnosis
-
Warts / drug therapy*
Substances
-
Adjuvants, Immunologic
-
Aminoquinolines
-
Ointments
-
Imiquimod